ArticleFrontiers in public health2026
Mediterranean diet adherence among women attending mobile breast cancer prevention programme: results of a cross-sectional study in Italy.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Mediterranean Diet (MedDiet) has been linked to lower breast cancer incidence through anti-inflammatory and antioxidant effects. This study evaluated adherence to the MedDiet among women undergoing mammographic screening provided by mobile units in Italy and explored its association with breast cancer risk factors. Materials and methods: A cross-sectional study was carried out between January and December 2023 as part of the mobile "Prevention Caravan programme." Eligible participants included women aged 18 years or older who underwent breast ultrasound or mammography and completed the 14-item "Mediterranean Diet Adherence Screener (MEDAS)." Descriptive analyses and differences across groups defined by known breast cancer risk factors, stratified by MedDiet adherence levels, were performed, and a multivariable logistic regression analysis was conducted to further explore these patterns. Results: A total of 7,492 women were included, most of whom were ≤45 years of age (69%) and from Central Italy (59%). The mean MEDAS score was 7.0 (SD 1.6), with 62% categorized as having low adherence to the MedDiet. Only 1.21% of participants achieved an excellent level of adherence to the MedDiet. MEDAS score increased with increasing age ( Conclusion: Mobile programmes like the "Prevention Caravan programme" may help promote healthy lifestyles and improve access to prevention services. Future studies should confirm these results in larger, more diverse populations and explore associations with lesion type and severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.